Table 4 Relationships between the level of ADSQ and the clinicopathological characteristics in 601 lung cancer patients.
Characteristics | Total | ADSQ | AD | SQ | P valuea |
|---|---|---|---|---|---|
Total | 601 | 11 | 403 | 187 | Â |
Gender | Â | Â | Â | Â | Â |
   Male | 398 | 6 (54.5) | 226 (56.1) | 166 (88.8) |  |
   Female | 203 | 5 (45.5) | 177 (43.9) | 21 (11.2) | 0.9194/0.0011 |
Age (y) | Â | Â | Â | Â | Â |
   <70 | 286 | 5 (45.5) | 210 (52.1) | 71 (38.0) |  |
   ≥70 | 315 | 6 (54.5) | 193 (47.9) | 116 (62.0) | 0.017/0.6198 |
Pathologic stage | Â | Â | Â | Â | Â |
   I-II | 460 | 5 (45.5) | 338(83.8) | 117 (62.6) |  |
   III-IV | 141 | 6 (54.5) | 65 (16.1) | 70 (37.4) | < 0.01/0.2567 |
pT | Â | Â | Â | Â | Â |
   T1-2 | 521 | 6 (54.5) | 375 (93.1) | 140 (74.9) |  |
   T3-4 | 80 | 5 (45.5) | 28 (6.9) | 47 (25.1) | < 0.0001/0.1367 |
PN | Â | Â | Â | Â | Â |
   N0 | 411 | 5 (45.5) | 313 (77.7) | 93 (49.7) |  |
   N1-2 | 190 | 6 (54.5) | 90 (22.3) | 94 (52.2) | 0.013/0.7564 |
Double ca | Â | Â | Â | Â | Â |
   Yes | 123 | 5 (45.5) | 85 (21.1) | 33 (17.6) | 0.053/0.023 |
   No | 478 | 6 (54.5) | 318 (78.9) | 154 (82.3) |  |